Mike Sciandra grew up around gamblers. It wasn’t long before he became one. He gambled for more than 20 years, declaring bankruptcy twice. He knew he had a problem, but it wasn’t until he entered treatment that he realized it was a gambling addiction.

In today’s episode, you’ll hear Sciandra tell his story to Senior Writer Anastassia Gliadkovskaya. The interview was recorded as part of a story published this week on the state of gambling addiction in the U.S.

To learn more about the topics in this episode: 
‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
Gambling addiction startup Birches Health to expand offerings, provider training under new clinical VP

If you or someone you know is struggling, contact 1-800-MY-RESET for the National Problem Gambling Helpline.

Mike Sciandra grew up around gamblers. It wasn&rsquo;t long before he became one. He gambled for more than 20 years, declaring bankruptcy twice. He knew he had a problem, but it wasn&rsquo;t until he entered treatment that he realized it was a gambling addiction.
In today&rsquo;s episode, you&rsquo;ll hear Sciandra tell his story to Senior Writer Anastassia Gliadkovskaya. The interview was recorded as part of a story published this week on the state of gambling addiction in the U.S.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/providers/next-opioid-epidemic-gambling-addiction-grows-legalization-outpaces-public-health">&lsquo;The next opioid epidemic&rsquo;: Gambling legalization outpaces public health response to addiction</a></li>
<li><a href="https://www.fiercehealthcare.com/digital-health/gambling-addiction-provider-birches-health-hires-clinical-vp">Gambling addiction startup Birches Health to expand offerings, provider training under new clinical VP</a></li>
</ul>
If you or someone you know is struggling, contact 1-800-MY-RESET for the National Problem Gambling Helpline.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

One man’s journey from gambling addiction to recovery and advocacy

In this sponsored episode of Podnosis, experts examine how molecular residual disease testing is transforming how clinicians assess recurrence risk in triple-negative breast cancer. Drawing on new data from the NSABP B-59 substudy presented at SABCS and AACR, the discussion highlights how circulating tumor DNA is providing earlier and more precise insight into patient outcomes.

Dr. Priya Rastogi, chief medical officer of the NSABP Foundation, explains how MRD testing can detect residual disease that standard tools may miss, often months or years before clinical recurrence. The conversation explores key findings, including the strong correlation between post-surgical ctDNA positivity and recurrence risk, as well as the prognostic value of ctDNA status earlier in the treatment pathway.

In this sponsored episode of Podnosis, experts examine how molecular residual disease testing is transforming how clinicians assess recurrence risk in triple-negative breast cancer. Drawing on new data from the NSABP B-59 substudy presented at SABCS and AACR, the discussion highlights how circulating tumor DNA is providing earlier and more precise insight into patient outcomes. Dr. Priya Rastogi, chief medical officer of the NSABP Foundation, explains how MRD testing can detect residual disease that standard tools may miss, often months or years before clinical recurrence. The conversation explores key findings, including the strong correlation between post-surgical ctDNA positivity and recurrence risk, as well as the prognostic value of ctDNA status earlier in the treatment pathway.

How MRD Testing Is Reshaping Breast Cancer Risk Assessment (Sponsored)

Condoms can be purchased almost anywhere, from big retailers to small convenience stores. The same can’t be said for female birth control. One company is trying to change that.

Cadence OTC sells the morning-after pill, a cheaper alternative to Plan B. Recognizing that many communities in the U.S. are pharmacy deserts, the company is pursuing atypical distribution channels such as convenience stores and gas stations to get emergency contraceptives into the hands of more Americans. Cadence is also advocating for a daily birth control pill to be made available over the counter.

Senior Writer Anastassia Gliadkovskaya sits down with Cadence OTC co-founder and CEO Samantha Miller to discuss how this approach could reshape reproductive healthcare and what policy and awareness challenges remain.

To learn more about the topics in this episode: 
Insurers not covering 12-month contraception supply as required: study
The quiet collapse of America's reproductive health safety net
Perrigo's over-the-counter birth control launch takes flight in the US
Amid Trump victory, women's health providers see flood of orders for contraception, abortion pills

Condoms can be purchased almost anywhere, from big retailers to small convenience stores. The same can&rsquo;t be said for female birth control. One company is trying to change that.
Cadence OTC sells the morning-after pill, a cheaper alternative to Plan B. Recognizing that many communities in the U.S. are pharmacy deserts, the company is pursuing atypical distribution channels such as convenience stores and gas stations to get emergency contraceptives into the hands of more Americans. Cadence is also advocating for a daily birth control pill to be made available over the counter.
Senior Writer Anastassia Gliadkovskaya sits down with Cadence OTC co-founder and CEO Samantha Miller to discuss how this approach could reshape reproductive healthcare and what policy and awareness challenges remain.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/payers/insurers-not-covering-12-month-contraception-supply-required-study">Insurers not covering 12-month contraception supply as required: study</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/quiet-collapse-americas-reproductive-health-safety-net">The quiet collapse of America's reproductive health safety net</a></li>
<li><a href="https://www.fiercepharma.com/pharma/perrigos-over-counter-birth-control-launch-takes-flight-us">Perrigo's over-the-counter birth control launch takes flight in the US</a></li>
<li><a href="https://www.fiercehealthcare.com/digital-health/amid-trump-victory-womens-health-providers-see-flood-orders-contraception-abortion">Amid Trump victory, women's health providers see flood of orders for contraception, abortion pills</a></li>
</ul>

The push to expand access to emergency contraception

Maternal and infant health remains a significant challenge across the country. To support better outcomes for both pregnant women and their babies, industry giant UnitedHealth Group is investing in doulas. Its insurance arm recently expanded a doula support program nationwide in its employer plans. 

In this episode, Fierce Senior Writer Paige Minemyer sits down with Catherine Anderson, senior vice president for health optimization strategy at UnitedHealth Group, to discuss how doulas can support the pregnancy journey and the role they can play in broader community health efforts. 

To learn more about the topics in this episode: 
UnitedHealthcare expands doula benefit to employers nationwide
Exclusive: Medicaid insurers can do more to improve maternal health access, HHS report says
Doulas, once a luxury, are increasingly covered by Medicaid—even in GOP states
Massachusetts Blues launches new doula pilot program, caregiving support

Maternal and infant health remains a significant challenge across the country. To support better outcomes for both pregnant women and their babies, industry giant UnitedHealth Group is investing in doulas. Its insurance arm recently expanded a doula support program nationwide in its employer plans.&nbsp;
In this episode, Fierce Senior Writer Paige Minemyer sits down with Catherine Anderson, senior vice president for health optimization strategy at UnitedHealth Group, to discuss how doulas can support the pregnancy journey and the role they can play in broader community health efforts.&nbsp;
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/payers/unitedhealthcare-expands-doula-benefit-employers-nationwide">UnitedHealthcare expands doula benefit to employers nationwide</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/exclusive-medicaid-insurers-can-do-more-improve-maternal-health-access-hhs-report-says">Exclusive: Medicaid insurers can do more to improve maternal health access, HHS report says</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/doulas-once-luxury-are-increasingly-covered-medicaid-even-gop-states">Doulas, once a luxury, are increasingly covered by Medicaid&mdash;even in GOP states</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/massachusetts-blues-launches-new-doula-caregiving-support">Massachusetts Blues launches new doula pilot program, caregiving support</a></li>
</ul>

One man’s journey from gambling addiction to recovery and advocacy

Podnosis

In 1 playlist(s)

Podnosis

Social links

Follow podcast

Recent clips